13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 88 holding rows worth $2,997,744,331.
- Accession
- 0001420506-26-001145
- Filer
- CIK 1920938
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 88 entries on the cover page, a total value of $2,997,744,331 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,997,744,331 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CARIS LIFE SCIENCES INC | 142152107 | COMMON STOCK | 8,009,447 | $143,208,912 | dollars as filed | |
| GUARDANT HEALTH INC | 40131MAD1 | DEBT 1.250% 2/1 | 60,954,000 | $102,575,501 | dollars as filed | principal |
| REPLIGEN CORP | 759916AD1 | NOTE 1.000%12/1 | 101,000,000 | $98,677,000 | dollars as filed | principal |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 100,381,000 | $91,848,615 | dollars as filed | principal |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 652,121 | $85,910,421 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 763,505 | $82,198,948 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,986,768 | $78,914,425 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,338,452 | $77,830,984 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 899,364 | $75,474,627 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,347,583 | $73,948,865 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 610,192 | $72,014,860 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 700,429 | $71,758,951 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,818,665 | $69,327,510 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 984,783 | $66,650,113 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081GAD4 | NOTE 0.750% 3/1 | 61,621,000 | $63,389,523 | dollars as filed | principal |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 84,939 | $62,026,705 | dollars as filed | |
| HINGE HEALTH INC A | 433313103 | COMMON STOCK | 1,455,123 | $56,109,543 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 2,471,199 | $55,008,890 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 3,206,574 | $52,748,142 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 182,425 | $47,124,026 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 932,823 | $47,051,592 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 499,712 | $46,158,397 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 92,915 | $45,670,510 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 3,592,999 | $44,912,488 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 1,492,467 | $44,550,140 | dollars as filed | |
| BRIGHTSPRING HEALTH SVCS | 10950A106 | COM | 1,016,562 | $43,315,707 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,356,082 | $43,014,921 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 5,617,402 | $41,681,123 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 478,667 | $40,289,401 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 539,708 | $39,382,493 | dollars as filed | |
| CAREDX INC | 14167L103 | COM | 2,173,146 | $37,725,815 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 77,297 | $35,633,144 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 677,570 | $34,949,061 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 105,352 | $34,594,436 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 329,391 | $32,744,759 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 959,259 | $32,115,991 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,681,998 | $30,494,624 | dollars as filed | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 10,240,164 | $28,979,664 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 229,215 | $28,253,041 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 337,559 | $28,115,289 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 497,020 | $28,076,660 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,750,766 | $27,136,873 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 310,628 | $27,015,317 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 139,327 | $26,416,399 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 463,600 | $26,323,208 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 847,151 | $26,185,437 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 129,000 | $25,798,710 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,752,798 | $25,643,435 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 3,134,922 | $24,044,852 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 3,988,989 | $23,734,485 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 2,172,725 | $23,639,248 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 894,846 | $23,176,511 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 346,467 | $21,740,804 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 523,824 | $21,073,440 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 1,200,587 | $20,998,267 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 290,700 | $20,878,074 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 265,715 | $18,639,907 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 62,080 | $18,173,920 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 1,100,370 | $17,462,872 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 2,456,870 | $16,731,285 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 222,701 | $16,023,337 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 645,900 | $15,107,601 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,128,040 | $14,292,267 | dollars as filed | |
| AVEANNA HEALTHCARE HLDGS INC | 05356F105 | COM | 2,203,506 | $14,190,579 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 3,272,954 | $13,517,300 | dollars as filed | |
| ZENAS BIOPHARMA INC | 98937LAA3 | NOTE 2.500% 4/0 | 13,000,000 | $13,455,000 | dollars as filed | principal |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 272,522 | $13,121,934 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 3,105,209 | $12,762,409 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 358,800 | $11,919,336 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 396,100 | $11,538,393 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 330,000 | $10,804,200 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 1,529,675 | $10,478,274 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,965,106 | $10,395,411 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 130,862 | $9,826,428 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 900,000 | $9,270,000 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 466,774 | $8,327,248 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 84,900 | $8,256,525 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 142,755 | $7,377,578 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,699,116 | $6,371,685 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 296,324 | $5,689,421 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 47,500 | $5,596,450 | dollars as filed | |
| HARROW INC | 415858109 | COM | 156,419 | $5,515,334 | dollars as filed | |
| REVVITY INC | 714046109 | COM | 48,400 | $4,240,324 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 29,198 | $3,332,660 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 9,976 | $3,214,167 | dollars as filed | |
| Arrowhead Pharmaceuticals In Note 1/1 | 04280AAC4 | Convertible | 2,250,000 | $2,333,475 | dollars as filed | principal |
| PULMONX CORP | 745848101 | COM | 752,541 | $970,778 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 916,077 | $547,356 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-001145 | this filing | 2026-05-15 | acceptance time not in the bulk data set |